A Randomized Phase 2 Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With and Without BMX-001 as Part of Total Neoadjuvant Therapy in Patients With Newly Diagnosed Locally Advanced Rectal Adenocarcinoma
Latest Information Update: 05 Feb 2024
At a glance
- Drugs BMX 001 (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 01 Feb 2024 Planned End Date changed from 1 Dec 2033 to 1 Jun 2029.
- 01 Feb 2024 Planned primary completion date changed from 1 May 2028 to 1 May 2027.
- 23 Jan 2024 Planned End Date changed from 1 Dec 2032 to 1 Dec 2033.